<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01893840</url>
  </required_header>
  <id_info>
    <org_study_id>OT-FO-01</org_study_id>
    <nct_id>NCT01893840</nct_id>
  </id_info>
  <brief_title>Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg</brief_title>
  <official_title>Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Otivio AS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Research Council of Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Otivio AS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to assess the effect of negative pulsating pressure therapy on patients with impaired
      blood flow to the leg caused by arterial disease, to see if the FlowOx device will increase
      the blood flow to the leg in these patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of the prescribed cycles delivered in the specified time FlowOx™-induced change in arterial leg blood flow (LBF)</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>This is calculated as the difference between the blood flow during the period using FlowOx™ (middle value over a period of 5 minutes) and baseline blood flow (middle value over a period of 5 prior to using FlowOx™)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient comfort measured by asking the patient a fixed set of questions</measure>
    <time_frame>up to 1 hour</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Fitting time</measure>
    <time_frame>up to 1 hour</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Periferal Arterial Occlusive Disease, PAOD</condition>
  <arm_group>
    <arm_group_label>FlowOx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 minutes of pulsating negative pressure (10 sek og -40mmHg/7 sek of athmospheric pressure) will be Applied to the patient's leg</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FlowOx</intervention_name>
    <description>Boot-shaped pressure chamber generating pulsating negative pressure</description>
    <arm_group_label>FlowOx</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written Informed Consent

          -  Age 30-90 years

          -  Affected foot/shoe sise less than 46 (approximate foot length less than 29.5 cm)

          -  Patients with Peripheral Arterial Occlusive Disease (PAOD) grade 2,3 or 4, i.e.:

               1. Clinically verified grade 2, i.e. Intermittent Claudication:

                    -  Ancle-Brachial Index (ABI)less than 0.9 or

                    -  Toe brachial Index (TBI) less than 0.7 or

                    -  Ultrasound and/or CT/Magnetic Resonance (MR) angiography suggesting
                       stenosis(es)and/or occlusion(s)

               2. Clinically verified grade 3, i.e. Critical Limb Ischemia (CLI):

                    -  ABI less than 0.4 or

                    -  Toe pressure less than 30 mmHg

                    -  Rest pain since at least 2 weeks or

                    -  Use of analgesics for rest pain for at least 2 weeks or

                    -  Ultrasound and/or CT/Magnetic Resonance (MR) angiography suggesting
                       stenosis(es)and/or occlusion(s)

               3. Clinically verified grade 4, i.e. CLI:

                    -  Ischemic ulcers or gangrene/tissue loss

                    -  ABI less than 0.4

                    -  Toe pressure less than 30 mmHg

                    -  Rest pain since at least 2 weeks or

                    -  Use of analgesics for rest pain for at least 2 weeks or

                    -  Ultrasound and/or CT/MR angiography suggesting stenosis(es)and/or
                       occlusion(s)

        Exclusion Criteria:

          -  Grade 1 PAOD

          -  Incapable of consenting voluntarily

          -  Fewer higher than 39 degrees Centigrade

          -  Severe Chronic Obstructive Pulmonary Disease (COPD)

          -  Severe heart disease such as unstable angina, severe heart failure and severe valve
             failure

          -  Severe Polyneurophathy

          -  Verified Osteomyelitis other than in the Phanlanx

          -  Currently treated for cancer and With a life expectancy of less than 2 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarlis Wesche, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lørenskog</city>
        <zip>N-1478</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2013</study_first_submitted>
  <study_first_submitted_qc>July 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2013</study_first_posted>
  <last_update_submitted>October 30, 2013</last_update_submitted>
  <last_update_submitted_qc>October 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

